Idiopathic pulmonary fibrosis (IPF) is a progressive disease with unclear etiology. IPF patients decline with heterogeneous trajectories. The ability to determine an individual’s disease course is limited to pulmonary function measurement... View Article
Tag Archive: IPF
Computed tomographic biomarkers in idiopathic pulmonary fibrosis – the future of quantitative analysisJanuary 1, 2019 12:03 pm
WU et al.
AJRCCM Issues > Vol. 199, No. 1 | Jan 01, 2019
Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA) – a phase 2a randomized placebo-controlled trialMay 28, 2018 12:45 pm
Maher et al.
www.thelancet.com/respiratory Published online May 20, 2018